Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2025-11-05 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | Sale+OE | 3,892 | $473.79 | $1,843,990.68 | -52.7% | → |
| 2025-09-08 | Cuffe Michael S. | EVP and Chief Clinical Officer | Sale+OE | 3,836 | $418.84 | $1,606,670.24 | -10.9% | → |
| 2025-05-13 | Foster Jon M | EVP and COO | Sell | 15,698 | $369.32 | $5,797,660.71 | -55.4% | → |
| 2025-02-14 | Berres Jennifer | SVP & Chief Human Res. Officer | Sell | 9,533 | $322.59 | $3,075,240.23 | -20.8% | → |
| 2024-11-14 | Whalen Kathleen M | SVP & Chief Ethics Officer | Sell | 1,474 | $357.99 | $527,677.26 | -13.5% | → |
| 2024-11-14 | Billington Phillip G | SVP-Internal Audit Services | Sale+OE | 3,897 | $350.00 | $1,363,950.00 | -6.9% | → |
| 2024-11-14 | Akdamar Erol R | Group President | Sale+OE | 2,900 | $353.00 | $1,023,700.00 | -29.8% | → |
| 2024-09-12 | Cuffe Michael S. | EVP and Chief Clinical Officer | Sale+OE | 8,358 | $385.42 | $3,221,340.36 | -22.0% | → |
| 2024-07-31 | Whalen Kathleen M | SVP & Chief Ethics Officer | Sale+OE | 4,851 | $362.13 | $1,756,695.25 | -18.1% | → |
| 2024-07-29 | Reiner Deborah M | SVP - Mktg. & Communications | Sell | 3,314 | $359.96 | $1,192,914.40 | -48.6% | → |
| 2024-07-29 | Wyatt Christopher F. | SVP & Controller | Sale+OE | 4,000 | $360.20 | $1,440,782.40 | -9.0% | → |
| 2024-07-25 | Torres Kathryn A. | SVP-Payer Contracting & Align. | Sell | 1,857 | $355.05 | $659,327.85 | -9.5% | → |
| 2024-05-16 | Whalen Kathleen M | SVP & Chief Ethics Officer | Sale+OE | 3,204 | $326.30 | $1,045,465.20 | -25.3% | → |
| 2024-05-15 | Torres Kathryn A. | SVP-Payer Contracting & Align. | Sell | 1,863 | $326.18 | $607,673.15 | -8.7% | → |
| 2024-05-09 | Cuffe Michael S. | EVP and Chief Clinical Officer | Sell | 6,311 | $316.88 | $1,999,824.63 | -17.6% | → |
| 2024-05-09 | Cohen Jeffrey E. | SVP-Government Relations | Sell | 1,650 | $313.00 | $516,450.00 | -24.1% | → |
| 2024-05-06 | Cuffe Michael S. | EVP and Chief Clinical Officer | Sale+OE | 1,600 | $309.00 | $494,400.00 | -4.5% | → |
| 2024-05-03 | Torres Kathryn A. | SVP-Payer Contracting & Align. | Sell | 1,863 | $312.00 | $581,256.00 | -4.1% | → |
| 2024-03-20 | Wasserman Chad J | SVP and CIO | Sale+OE | 1,220 | $327.92 | $400,056.68 | -23.2% | → |
| 2024-02-09 | Whalen Kathleen M | SVP & Chief Ethics Officer | Sell | 4,262 | $306.21 | $1,305,074.27 | -29.4% | → |
| 2024-02-06 | RUTHERFORD BILL B | CFO and EVP | Sale+OE | 6,000 | $310.63 | $1,863,780.00 | -41.5% | → |
| 2024-02-05 | Wyatt Christopher F. | SVP & Controller | Sell | 4,000 | $312.42 | $1,249,680.00 | -9.7% | → |
| 2024-02-05 | Mosier Sammie S | SVP & Chief Nurse Executive | Sale+OE | 1,645 | $312.00 | $513,240.00 | -17.7% | → |
| 2024-02-02 | Wasserman Chad J | SVP and CIO | Sale+OE | 652 | $312.04 | $203,450.54 | -69.2% | → |
| 2024-01-31 | Cuffe Michael S. | EVP and Chief Clinical Officer | Sell | 3,200 | $306.79 | $981,733.76 | -11.4% | → |
| 2024-01-31 | Torres Kathryn A. | SVP-Payer Contracting & Align. | Sale+OE | 3,861 | $307.00 | $1,185,327.00 | -19.5% | → |
| 2023-08-14 | Torres Kathryn A. | SVP-Payer Contracting & Align. | Sell | 5,204 | $269.12 | $1,400,515.57 | -20.8% | → |
| 2023-08-11 | Cohen Jeffrey E. | SVP-Government Relations | Sell | 1,500 | $270.00 | $405,000.00 | -25.4% | → |
| 2023-08-03 | Whalen Kathleen M | SVP & Chief Ethics Officer | Sell | 2,916 | $270.00 | $787,320.00 | -22.1% | → |
| 2023-04-28 | Cuffe Michael S. | EVP and Chief Clinical Officer | Sell | 12,556 | $284.44 | $3,571,395.99 | -30.4% | → |
| 2023-04-28 | Akdamar Erol R | Group President | Sell | 3,500 | $285.00 | $997,500.00 | -7.6% | → |
| 2023-04-24 | Torres Kathryn A. | SVP-Payer Contracting & Align. | Sell | 4,473 | $288.38 | $1,289,913.00 | -16.7% | → |
| 2023-04-14 | Paslick P. Martin | SVP and CIO | Sale+OE | 2,687 | $275.00 | $738,925.00 | -9.8% | → |
| 2023-04-10 | Paslick P. Martin | SVP and CIO | Sell | 2,539 | $270.00 | $685,530.00 | -9.3% | → |
| 2023-04-04 | Paslick P. Martin | SVP and CIO | Sale+OE | 3,034 | $265.00 | $804,010.00 | -11.0% | → |
| 2023-02-17 | Whalen Kathleen M | SVP & Chief Ethics Officer | Sell | 1,734 | $263.61 | $457,096.79 | -14.8% | → |
| 2023-02-07 | Berres Jennifer | SVP & Chief Human Res. Officer | Sell | 4,000 | $255.23 | $1,020,912.00 | -35.1% | → |
| 2023-02-03 | Reiner Deborah M | SVP - Mktg. & Communications | Sell | 7,941 | $257.61 | $2,045,699.27 | -100% | → |
| 2023-02-03 | RUTHERFORD BILL B | CFO and EVP | Sale+OE | 30,000 | $258.19 | $7,745,568.00 | -26.9% | → |
| 2023-02-02 | Akdamar Erol R | Group President | Sale+OE | 3,000 | $258.63 | $775,891.20 | -8.0% | → |
| 2023-02-01 | Wyatt Christopher F. | SVP & Controller | Sale+OE | 4,900 | $253.30 | $1,241,170.00 | -13.1% | → |
| 2023-02-01 | Foster Jon M | EVP and COO | Sale+OE | 16,424 | $251.98 | $4,138,480.10 | -60.0% | → |
| 2023-02-01 | Paslick P. Martin | SVP and CIO | Sell | 1,000 | $256.95 | $256,948.70 | -25.0% | → |
| 2023-02-01 | Cuffe Michael S. | EVP and Chief Clinical Officer | Sell | 4,000 | $257.11 | $1,028,440.40 | -16.1% | → |
| 2023-01-30 | McManus Timothy M | Group President | Sell | 7,900 | $254.06 | $2,007,067.16 | -22.0% | → |